|
1
|
Kural-Seyahi E, Fresko I, Seyahi N,
Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S and Yazici H: The
long-term mortality and morbidity of Behçet syndrome: A 2-decade
outcome survey of 387 patients followed at a dedicated center.
Medicine (Baltimore). 82:60–76. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Khairallah M, Accorinti M, Muccioli C,
Kahloun R and Kempen JH: Epidemiology of Behçet disease. Ocul
Immunol Inflamm. 20:324–335. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
LeBien TW and Tedder TF: B lymphocytes:
How they develop and function. Blood. 112:1570–1580. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suzuki N, Sakane T, Ueda Y and Tsunematsu
T: Abnormal B cell function in patients with Behçet's disease.
Arthritis Rheum. 29:212–219. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ekşioglu-Demiralp E, Kibaroglu A,
Direskeneli H, Yavuz S, Karsli F, Yurdakul S, Yazici H and Akoglu
T: Phenotypic characteristics of B cells in Behçet's disease:
Increased activity in B cell subsets. J Rheumatol. 26:826–832.
1999.PubMed/NCBI
|
|
6
|
Hamzaoui K, Houman H, Ben Dhifallah I,
Kamoun M and Hamzaoui A: Serum BAFF levels and skin mRNA expression
in patients with Behçet's disease. Clin Exp Rheumatol. 26:64–71.
2008.
|
|
7
|
Imamura Y, Kurokawa MS, Yoshikawa H, Nara
K, Takada E, Masuda C, Tsukikawa S, Ozaki S, Matsuda T and Suzuki
N: Involvement of Th1 cells and heat shock protein 60 in the
pathogenesis of intestinal Behcet's disease. Clin Exp Immunol.
139:371–378. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Geri G, Terrier B, Rosenzwajg M, Wechsler
B, Touzot M, Seilhean D, Tran TA, Bodaghi B, Musset L, Soumelis V,
et al: Critical role of IL-21 in modulating TH17 and regulatory T
cells in Behçet disease. J Allergy Clin Immunol. 128:655–664. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hughes T, Ture-Ozdemir F, Alibaz-Oner F,
Coit P, Direskeneli H and Sawalha AH: Epigenome-wide scan
identifies a treatment-responsive pattern of altered DNA
methylation among cytoskeletal remodeling genes in monocytes and
CD4+ T cells from patients with Behçet's disease. Arthritis
Rheumatol. 66:1648–1658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pedraza-Alva G and Rosenstein Y: CD43- One
molecule, many tales to recount. Signal Transduct. 7:372–385. 2007.
View Article : Google Scholar
|
|
11
|
Liang ZB, Zhang SF and Xu J: CD43
preliminary study of expression of CD43 antigen on lymphocytes of
peripheral blood in patients with SLE. Zhonghua Pifuke Zazhi.
31:14–18. 1998.
|
|
12
|
Parkman R, Remold-O'Donnell E, Kenney DM,
Perrine S and Rosen FS: Surface protein abnormalities in
lymphocytes and platelets from patients with Wiskott-Aldrich
syndrome. Lancet. 2:1387–1389. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gallego MD, Aguado E, Kindelán JM, Peña J,
Santamaría M and Molina IJ: Altered expression of
CD43-hexasaccharide isoform on peripheral T lymphocytes from
HIV-infected individuals. AIDS. 15:477–481. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park SR: Activation-induced cytidine
deaminase in B cell immunity and cancer. Immune Netw. 12:230–239.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nussenzweig MC and Alt FW: Antibody
diversity: One enzyme to rule them all. Nat Med. 10:1304–1305.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu HC, Wu Y, Yang P, Wu Q, Job G, Chen J,
Wang J, Accavitti-Loper MAV, Grizzle WE, Carter RH, et al:
Overexpression of activation-induced cytidine deaminase in B cells
is associated with production of highly pathogenic autoantibodies.
J Immunol. 178:5357–5365. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang C, Foley J, Clayton N, Kissling G,
Jokinen M, Herbert R and Diaz M: Abrogation of lupus nephritis in
activation-induced deaminase-deficient MRL/lpr mice. J Immunol.
178:7422–7431. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zan H, Zhang J, Ardeshna S, Xu Z, Park SR
and Casali P: Lupus-prone MRL/faslpr/lpr mice display increased AID
expression and extensive DNA lesions, comprising deletions and
insertions, in the immunoglobulin locus: Concurrent upregulation of
somatic hypermutation and class switch DNA recombination.
Autoimmunity. 42:89–103. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jiang C, Zhao ML and Diaz M:
Activation-induced deaminase heterozygous MRL/lpr mice are delayed
in the production of high-affinity pathogenic antibodies and in the
development of lupus nephritis. Immunology. 126:102–113. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
DiLillo DJ, Matsushita T and Tedder TF:
B10 cells and regulatory B cells balance immune responses during
inflammation, autoimmunity, and cancer. Ann N Y Acad Sci.
1183:38–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsushita T, Yanaba K, Bouaziz JD,
Fujimoto M and Tedder TF: Regulatory B cells inhibit EAE initiation
in mice while other B cells promote disease progression. J Clin
Invest. 118:3420–3430. 2008.PubMed/NCBI
|
|
22
|
Mauri C and Bosma A: Immune regulatory
function of B cells. Annu Rev Immunol. 30:221–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yanaba K, Bouaziz JD, Haas KM, Poe JC,
Fujimoto M and Tedder TF: A regulatory B cell subset with a unique
CD1dhi CD5+ phenotype controls T cell-dependent inflammatory
responses. Immunity. 28:639–650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Anderson AC, Reddy J, Nazareno R, Sobel
RA, Nicholson LB and Kuchroo VK: IL-10 plays an important role in
the homeostatic regulation of the autoreactive repertoire in naive
mice. J Immunol. 173:828–834. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moore KW, de Waal Malefyt R, Coffman RL
and O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu
Rev Immunol. 19:683–765. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maseda D, Smith SH, DiLillo DJ, Bryant JM,
Candando KM, Weaver CT and Tedder TF: Regulatory B10 cells
differentiate into antibody-secreting cells after transient IL-10
production in vivo. J Immunol. 188:1036–1048. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Weichsler B, Davatchi F, Mizushima Y,
Hamza M, Dilsen N, Kansu E, Yazici H, Barnes CG, Chamberlain MA,
James DG, et al: International Study Group for Behçet's Disease:
Criteria for diagnosis of Behçet's disease. Lancet. 335:1078–1080.
1990.PubMed/NCBI
|
|
28
|
Fuss IJ, Kanof ME, Smith PD and Zola H:
Isolation of whole mononuclear cells from peripheral blood and cord
blood. Curr Protoc Immunol. 85:7.1.1–7.1.8. 2009.https://doi.org/10.1002/0471142735.im0701s85
|
|
29
|
Miltenyi S, Müller W, Weichel W and
Radbruch A: High gradient magnetic cell separation with MACS.
Cytometry. 11:231–238. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cho SB, Ahn KJ, Kim DH, Zheng Z, Cho S,
Kang SW, Lee JH, Park YB, Lee KH and Bang D: Identification of
HnRNP-A2/B1 as a target antigen of anti-endothelial cell IgA
antibody in Behçet's disease. J Invest Dermatol. 132:601–608. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Altay M, Secilmis S, Unverdi S, Ceri M and
Duranay M: Behcet's disease and IgA nephropathy. Rheumatol Int.
32:2227–2229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barclay A, Brown M, Alex Law SK, McKnight
A, Tomlinson M and van der Merwe P: The Leukocyte Antigen
Factsbook. Academic press; London: 1997, View Article : Google Scholar
|
|
34
|
Inui M, Hirota S, Hirano K, Fujii H,
Sugahara-Tobinai A, Ishii T, Harigae H and Takai T: Human CD43+ B
cells are closely related not only to memory B cells phenotypically
but also to plasmablasts developmentally in healthy individuals.
Int Immunol. 27:345–355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hase K, Takahashi D, Ebisawa M, Kawano S,
Itoh K and Ohno H: Activation-induced cytidine deaminase deficiency
causes organ-specific autoimmune disease. PLoS One. 3:e30332008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang C, Zhao ML, Waters KM and Diaz M:
Activation-induced deaminase contributes to the
antibody-independent role of B cells in the development of
autoimmunity. Autoimmunity. 45:440–448. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu X, Darce JR, Chang SK, Nowakowski GS
and Jelinek DF: Alternative splicing regulates activation-induced
cytidine deaminase (AID): Implications for suppression of AID
mutagenic activity in normal and malignant B cells. Blood.
112:4675–4682. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Douglas RS, Woo EY, Capocasale RJ, Tarshis
AD, Nowell PC and Moore JS: Altered response to and production of
TGF-beta by B cells from autoimmune NZB mice. Cell Immunol.
179:126–137. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vitale G, Mion F and Pucillo C: Regulatory
B cells: Evidence, developmental origin and population diversity.
Mol Immunol. 48:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rawlings DJ, Schwartz MA, Jackson SW and
Meyer-Bahlburg A: Integration of B cell responses through Toll-like
receptors and antigen receptors. Nat Rev Immunol. 12:282–294. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nadler LM, Stashenko P, Hardy R, van
Agthoven A, Terhorst C and Schlossman SF: Characterization of a
human B cell-specific antigen (B2) distinct from B1. J Immunol.
126:1941–1947. 1981.PubMed/NCBI
|
|
42
|
Moore-Connors JM, Kim HS, Marshall JS,
Stadnyk AW, Halperin SA and Wang J: CD43-, but not CD43+,
IL-10-producing CD1dhiCD5+ B cells suppress type 1 immune responses
during Chlamydia muridarum genital tract infection. Mucosal
Immunol. 8:94–106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Barrat FJ, Cua DJ, Boonstra A, Richards
DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL,
Hawrylowicz CM and O'Garra A: In vitro generation of interleukin
10-producing regulatory CD4(+) T cells is induced by
immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and
Th2-inducing cytokines. J Exp Med. 195:603–616. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Romani L, Mencacci A, Cenci E, Spaccapelo
R, Del Sero G, Nicoletti I, Trinchieri G, Bistoni F and Puccetti P:
Neutrophil production of IL-12 and IL-10 in candidiasis and
efficacy of IL-12 therapy in neutropenic mice. J Immunol.
158:5349–5356. 1997.PubMed/NCBI
|
|
45
|
Morbach H, Eichhorn EM, Liese JG and
Girschick HJ: Reference values for B cell subpopulations from
infancy to adulthood. Clin Exp Immunol. 162:271–279. 2010.
View Article : Google Scholar : PubMed/NCBI
|
